BIOT

9:10 177. Rethinking affibody: Evolving small proteins using data-driven diversification. D.R. Woldring,
P.V. Holec, B. Hackel
9:30 178. Human G protein-coupled receptors expression and signaling in yeast: Design and optimization of
the host/protein platform for therapeutic development. A. Jain, A.S. Robinson
9:50 Intermission.
10:10 179. Bispecific antibody vs. binary mixture: Synergy in the treatment of pertussis. E. Wagner, J.
Maynard
10:30 180. Discovery of highly soluble antibodies prior to purification using affinity-capture self-interaction
nanoparticle spectroscopy. J. Wu, J.S. Schultz, C.L. Weldon, S.V. Sule, Q. Chai, S.B. Geng, C.D. Dickinson,
P.M. Tessier
10:50 181. Effect of culture medium and feeding conditions on antibody fragment secretion system in
Escherichia coli. C. Chen, W. Chi, C. Fan, H. Lu, Y. Wu, Y. Chen, C. Lin
11:10 182. Effect of air-liquid interface in monoclonal antibody aggregate formation. T.A. Mammo, B.
Constantine, M. Zhu, D. Robbins
Westin San Diego
Opal
Emerging Technologies
New Tools & Approaches
Section D
J. Latone, G. M. Thurber, I. R. Wheeldon, Organizers
B. Throndset, J. Wang, Organizers, Presiding
8:30 183. Site-specific covalent labeling of RNA with RNA-TAG: A robust technology applicable to a
variety of biologically relevant investigations. S.C. Alexander, N.K. Devaraj
8:50 184. New synthetic chemical biology approach for the development of HIV-1 vaccine. N. Wang, Z.
Yuan, W. Niu, Q. Li, J. Guo
9:10 185. Mimicking protein functions with entropically constrained peptides. B. Farrow, A. Wang, K.
Deyle, D. Bunck, J.R. Heath
9:30 186. Peptoid-based microsphere coating to increase the binding efficiency in sandwich ELISA
microarrays. G.R. Perez-Bakovic, S.L. Servoss
9:50 Intermission.
10:10 187. Disease screening pill for breast cancer: In vivo demonstration of an orally available near-infrared
molecular imaging agent using mouse xenografts. S. Bhatnagar, K. Dhingra, W. Kelley, J. Liao, A. Priluck,
G.M. Thurber